Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention

Treatment with low-dose prasugrel might be more beneficial even in chronic stable coronary artery disease (CAD) patients treated with clopidogrel. We compared platelet reactivity between standard maintenance-dose and low-dose prasugrel in stable CAD patients. This multicenter study enrolled 164 stab...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of cardiology 2022-06, Vol.356, p.30-35
Hauptverfasser:	Akimaru, Kaoru, Iwabuchi, Masashi, Ishida, Akio, Uehara, Hiroki, Higa, Namio, Kakazu, Masanori, Wake, Minoru, Maeda, Taketoshi, Maeda, Toshiki, Arima, Hisatomi, Ohya, Yusuke, Tokashiki, Shinta, Wakugawa, Hayashi, Miyagi, Ayane, Shiohira, Shinya, Zaima, Satoshi, Shiohira, Tomohiro, Toma, Yuichirou, Ikemiyagi, Hidekazu
Format:	Artikel
Sprache:	eng
Schlagworte:	Clopidogrel Coronary artery disease Coronary Artery Disease - diagnosis Coronary Artery Disease - drug therapy Coronary Artery Disease - surgery Cytochrome P-450 CYP2C19 - genetics Cytochrome P-450 CYP2C19 - metabolism Humans P2Y12 reaction unit Percutaneous Coronary Intervention - adverse effects Platelet aggregation Platelet Aggregation Inhibitors Prasugrel Prasugrel Hydrochloride - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!